Jiang, Mengmeng
Liu, Jia
Hu, Shengquan
Yan, Xueqin
Cao, Yongkai
Wu, Zhengzhi
Funding for this research was provided by:
National Natural Science Foundation of China (81574038, 81473742)
Article History
Received: 29 October 2024
Accepted: 11 February 2025
First Online: 5 March 2025
Declarations
:
: This research does not contain human cell lines or clinical experiments. All animal experiments were conducted in accordance with the animal use protocol approved by the Animal Research Ethics Committee of the Changchun University of Chinese Medicine (“Stem cell-derived exosomes enhance anti-tumor immunotherapy” Approve No. 2024690, approved April 15th, 2024).
: Not applicable.
: The authors declare that they have not used AI-generated work in this manuscript.
: All of the authors declare that they have no competing financial interests.